The effect of a maturing antiretroviral program on early mortality for patients with advanced immune-suppression in Soweto, South Africa

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Otwombe, Kennedy N ^a   Laher, Fatima ^a   Tutu Gxashe, Thandeka ^a   Gray, Glenda ^a   Mohapi, Lerato ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CRYPTOCOCCAL MENINGITIS; EPILEPSY; FEMALE; GASTROENTERITIS; HEALTH CARE PLANNING; HEALTH PROGRAM; HEART FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PROGRAM IMPACT; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SOUTH AFRICA; TIME OF DEATH; TIME TO TREATMENT; TUBERCULOSIS; CD4 LYMPHOCYTE COUNT; DRUG EFFECTS; HIV INFECTIONS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; RISK;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; MALE; RETROSPECTIVE STUDIES; RISK; SOUTH AFRICA;

EID: 84896725087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081538     Document Type: Article

References (23)

1. UNAIDS (2010) Global report: UNAIDS report on the global AIDS epidemic.
2. UNAIDS (2011) World AIDS Day Report.
3. WHO (2011) Global HIV/AIDS. Response.
4. Hoffmann CJ, Fielding KL, Johnston V, Charalambous S, Innes C et al. (2011) Changing predictors of mortality over time from cART start: implications for care. J Acquir Immune Defic Syndr 58: 269-276. doi:10.1097/QAI. 0b013e31823219d1. PubMed: 21876447.
5. Kouanda S, Meda IB, Nikiema L, Tiendrebeogo S, Doulougou B et al. (2012) Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 24: 478-490. PubMed: 22148973.
6. Mujugira A, Wester CW, Kim S, Bussmann S, Gaolathe T (2009) Patients with advanced HIV type 1 infection initiating antiretroviral therapy in Botswana: treatment response and mortality. AIDS Res Hum Retroviruses 25: 127-133. doi:10.1089/aid.2008.0172. PubMed: 19239353.
7. Stringer JSA, Zulu I, Levy J, Stringer EM, Mwango A et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia. JAMA 296: 782-793. doi:10.1001/jama.296.7.782. PubMed: 16905784. (Pubitemid 44223102)
8. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18: 887-895. doi:10.1097/00002030-200404090-00006. PubMed: 15060436. (Pubitemid 38553709)
9. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824. doi:10.1016/S0140-6736(06)68337-2. PubMed: 16530575.
10. Lawn SD, Myer L, Bekker LG, Wood R (2006) CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 6: 59. doi:10.1186/1471-2334-6-59.
11. Smit C, Hallett TB, Lange J, Garnett G, de Wolf F (2008) Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLOS ONE 3: e1949. doi:10.1371/journal.pone.0001949. PubMed: 18398473.
12. Jung AC, Paauw DS (1998) Diagnosing HIV-related disease: using the CD4 count as a guide. J Gen Intern Med 13: 131-136. doi:10.1046/j.1525-1497.1998. 00031.x. PubMed: 9502375. (Pubitemid 28092947)
13. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C et al. (2011) Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 365: 1492-1501. doi:10.1056/NEJMoa1014181. PubMed: 22010915.
14. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C et al. (2011) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 365: 1471-1481. doi:10.1056/NEJMoa1013911. PubMed: 22010913.
15. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365: 1482-1491. doi:10.1056/NEJMoa1013607. PubMed: 22010914.
16. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I et al. (2009) Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLOS ONE 4: e5575. doi:10.1371/journal.pone.0005575. PubMed: 19440326.
17. DoH (2004) South Africa Antiretroviral Treatment Guidelines. In: DO Health.
18. DoH (2010) South Africa Antiretroviral Treatment Guidelines. In: DO Health.
19. Alemu AW, Sebastián MS (2010) Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action 3: 5398. PubMed: 21042435.
20. Erikstrup C, Kallestrup P, Zinyama R, Gomo E, Mudenge B et al. (2007) Predictors of mortality in a cohort of HIV-1 infected adults in rural Africa. Journal of Acquired Immune Deficiency Syndromes 44: 478-483. doi:10.1097/QAI.0b013e318032bbcd. (Pubitemid 46555385)
21. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI et al. (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 8: 52. doi:10.1186/1471-2334-8- 52. PubMed: 18430196.
22. Ojikutu BO, Zheng H, Walensky RP, Lu Z, Losina E et al. (2008) Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J 98: 204-208. PubMed: 18350223. (Pubitemid 351516347)
23. Russell EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD et al. (2010) Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health 10: 433. doi:10.1186/1471-2458-10-433. PubMed: 20653940.